IFIT3 Associates with m⁶A-Modified RNA to Restrict Hepatitis C Virus Infection

This study reveals that IFIT3 restricts Hepatitis C Virus infection by specifically recognizing and binding to m⁶A-modified viral and host RNAs through distinct structural domains, thereby establishing a novel m⁶A-dependent antiviral mechanism.

The Gist

The Big Picture: A New Security Guard for Your Cells

Imagine your body is a massive, high-tech city. Inside this city, your cells are the buildings. Sometimes, viruses like Hepatitis C (HCV) try to break in, hijack the buildings, and turn them into virus factories.

To stop this, your city has a security force called the Interferon system. When a virus is spotted, the city sounds the alarm, and special "security guards" called IFIT proteins are deployed to hunt down the invaders.

For a long time, scientists knew about three of these guards:

• IFIT1 is like a bouncer who checks IDs at the door (looking for specific caps on RNA).
• IFIT2 is a detective who looks for specific patterns in the text of the virus.
• IFIT3 was the mystery guard. We knew it was on the team, but nobody knew exactly how it found the bad guys or what it was looking for.

This paper solves the mystery of IFIT3. It turns out IFIT3 is a specialist that looks for a very specific "sticker" on the virus's instructions.

---

The "Sticker" Analogy: The m⁶A Tag

Imagine the virus's genetic code (RNA) is a long instruction manual. Usually, the virus tries to hide its manual so the city's security doesn't notice it.

However, the city's own workers sometimes accidentally put a special glow-in-the-dark sticker on the manual. This sticker is called m⁶A (N6-methyladenosine).

• The Virus's Mistake: The virus uses the host's machinery to copy itself, and sometimes it gets these stickers on its own instructions.
• The Discovery: The researchers found that IFIT3 is a guard that specifically hunts for these glow-in-the-dark stickers. It doesn't care about the text of the manual; it just grabs anything with the sticker on it.

The Analogy:
Think of the virus as a thief trying to sneak into a bank. The bank (the cell) has a security system.

• Old Theory: The guards only looked for the thief's face (specific sequences).
• New Discovery: The guards (IFIT3) realized the thief accidentally left a glowing sticker on their backpack. The guard grabs anyone wearing that sticker, regardless of what they look like.

---

How They Figured It Out (The Detective Work)

The scientists used a clever trick called HyperTRIBE-seq.

• The Metaphor: Imagine they gave IFIT3 a pair of "magic highlighter pens" (an enzyme called ADAR).
• The Process: When IFIT3 grabbed onto an RNA molecule, the magic pen would scribble a mark on it.
• The Result: By reading all the scribbles, the scientists could see exactly which RNA molecules IFIT3 was holding.

What they found:

1. The Overlap: The places where IFIT3 grabbed RNA were almost exactly the same places where the "sticker" (m⁶A) was located.
2. The Proof: When they used a chemical to wipe the stickers off the RNA, IFIT3 stopped grabbing the virus. It was like taking the glow-in-the-dark sticker off the thief's backpack; the guard couldn't find him anymore.
3. The Specificity: They even built a fake virus with the stickers removed, and IFIT3 ignored it. But when they put the stickers back on, IFIT3 grabbed it tight.

---

The "Toolbelt" of the Guard: How IFIT3 Works

The paper also looked at the physical shape of the IFIT3 guard to see which parts of its body did the work.

• The "Hand" (Helical Hairpin): They found a specific part of the protein (a region between TPRs 6 and 7) that acts like a specialized hand. This hand is designed to grab the "sticker" (m⁶A). If you cut off this hand, the guard can't grab the virus, even if it's standing right next to it.
• The "Teammate Connector" (TPR 1-2): Another part of the protein is like a hook that connects IFIT3 to its partner, IFIT2.
• The Surprise: The scientists found that the "Hand" (for grabbing the virus) and the "Hook" (for holding the teammate) are in different places. This means IFIT3 can grab the virus on its own, but to be a truly effective security guard, it usually needs to hold hands with IFIT2 to do the heavy lifting.

---

The Final Showdown: Stopping the Virus from Leaving

The most important part of the story is what IFIT3 actually does once it grabs the virus.

• The Scenario: The virus is making copies of itself inside the cell. It wants to pack these copies into little "shipping containers" (virions) and send them out of the cell to infect other buildings.
• The Action: IFIT3 grabs the viral instructions that have the stickers on them.
• The Result: Because IFIT3 is holding onto the instructions, the virus can't pack them into the shipping containers. The virus gets stuck inside the cell.
• The Evidence: The scientists found that in cells with a working IFIT3, there was very little virus in the "street" (the liquid outside the cell), but plenty of virus stuck inside the "building."

The Metaphor:
IFIT3 is like a security guard who sees a delivery truck (the virus) trying to leave the warehouse. The guard grabs the cargo (the viral RNA) because it has a suspicious sticker. The truck can't leave because the cargo is being held hostage. The virus is trapped inside the cell and eventually destroyed.

Why This Matters

1. New Weapon: This gives us a new understanding of how our immune system fights viruses. It's not just about recognizing the virus's face; it's about recognizing the "glow-in-the-dark stickers" the virus accidentally wears.
2. Double-Edged Sword: Viruses use these stickers to hide from other parts of the immune system (like RIG-I). But this paper shows that IFIT3 turns that trick against them. The virus tries to hide, but the sticker actually flags it for a different, very effective guard.
3. Future Medicine: Understanding exactly how IFIT3 grabs these stickers could help scientists design new drugs that boost this specific guard, helping our bodies fight off Hepatitis C and potentially other viruses that use similar tricks.

In short: The paper reveals that our immune system has a specialized guard (IFIT3) that hunts viruses by grabbing onto a specific chemical "sticker" (m⁶A) that the virus accidentally puts on itself, effectively trapping the virus inside the cell and stopping it from spreading.

Technical Summary

1. Problem Statement

Interferon-induced proteins with tetratricopeptide repeats (IFITs) are critical RNA-binding effectors in the innate immune response against RNA viruses. While the mechanisms of RNA recognition for IFIT1 (cap0 recognition), IFIT2 (AU-rich sequences), and IFIT5 are well-characterized, the RNA-binding properties and specific recognition mechanisms of IFIT3 remain poorly understood. Historically, IFIT3 was viewed primarily as a cofactor that enhances the activity of IFIT1 or IFIT2 through heterocomplex formation. However, recent evidence suggests IFIT3 may have autonomous RNA-binding capabilities. The specific RNA features (sequence, structure, or chemical modifications) that govern IFIT3 binding, particularly during Hepatitis C Virus (HCV) infection, were unknown.

2. Methodology

The authors employed a multi-faceted approach combining transcriptome-wide mapping, biochemical assays, structural biology, and functional virology:

• HyperTRIBE-seq: To map IFIT3 RNA binding sites transcriptome-wide, the authors expressed an IFIT3-ADAR fusion protein (IFIT3 fused to the catalytic domain of hyperactive ADAR) in Huh7 cells during HCV infection. ADAR edits adenosine to inosine (read as guanosine) in RNA bound by the fusion protein. These editing events were identified via RNA-seq and compared against a control (ADAR-only) to distinguish specific IFIT3 binding from background noise.
• Comparative Bioinformatics: IFIT3 binding sites were compared against published CLIP-seq datasets for other RNA-binding proteins (RBPs), including m⁶A readers (YTHDFs, IGF2BPs) and other RBPs, to identify binding preferences.
• m⁶A Manipulation:
  • Chemical Inhibition: Cells were treated with STM2457, a METTL3 inhibitor, to reduce global m⁶A levels.
  • Genetic Mutation: Synonymous mutations were introduced into DRACH motifs (the consensus sequence for m⁶A methylation) within the HCV genome to abolish specific m⁶A sites.
• Biochemical Assays:
  • RNA Affinity Pulldowns: Biotinylated RNA probes (with or without m⁶A) were used to pull down IFIT3 from cell lysates.
  • Electrophoretic Mobility Shift Assays (EMSA): Purified recombinant IFIT3 was tested for binding to RNA probes.
  • Co-Immunoprecipitation (Co-IP): Used to assess interactions between IFIT3 and other IFIT family members (IFIT1, IFIT2).
• Domain Mapping: A series of deletion mutants of IFIT3 (targeting TPR domains and uncharacterized regions) were generated to map the specific structural elements required for RNA binding versus protein-protein interactions.
• Viral Restriction Assays: HCV infection was performed in cells expressing wild-type or mutant IFIT3 to measure intracellular vs. extracellular (supernatant) viral RNA levels.

3. Key Contributions

• Discovery of m⁶A-Dependent Binding: The study identifies N⁶-methyladenosine (m⁶A) as a critical determinant for IFIT3 recognition of both host and viral RNA.
• Structural Separation of Functions: The authors demonstrate that IFIT3's RNA-binding function is structurally separable from its role as a cofactor for IFIT1/IFIT2.
• Identification of a Novel RNA-Binding Domain: A previously uncharacterized helical hairpin (residues 274–324) within the uncharacterized region (UCR) of IFIT3 is identified as essential for direct RNA binding in cells.
• Mechanism of Restriction: The paper elucidates a mechanism where IFIT3 restricts HCV by targeting m⁶A-modified viral RNA, specifically limiting viral RNA release/packaging rather than inhibiting early replication.

4. Key Results

A. IFIT3 Binds m⁶A-Modified RNA

• Transcriptome-wide Mapping: HyperTRIBE-seq revealed that IFIT3 binds broadly to host and viral RNAs, with a strong enrichment in 3' UTRs.
• Overlap with m⁶A Readers: IFIT3 binding sites showed significant overlap with known m⁶A "reader" proteins (e.g., YTHDF2, IGF2BP2) and m⁶A peaks, but not with IFIT2 binding sites.
• Dependency on m⁶A:
  • Inhibiting METTL3 (m⁶A writer) significantly reduced IFIT3 association with HCV RNA and specific host transcripts (e.g., SELENOT).
  • IFIT3 preferentially co-purified with m⁶A-modified RNA probes compared to unmodified controls in cell lysates.
  • Mutating DRACH motifs in the HCV genome abolished IFIT3-ADAR editing at specific viral sites, confirming that cis-acting m⁶A motifs are required for recognition.

B. Structural Requirements for Binding

• Domain Analysis: Two regions were identified as critical for RNA binding: TPRs 1–2 and a helical hairpin (residues 274–324) between TPRs 6 and 7.
• Independence from IFIT1/2:
  • Deletion of the helical hairpin (Δ274–324) abolished HCV RNA binding in cells but did not disrupt interactions with IFIT1 or IFIT2.
  • Deletion of TPRs 1–2 (Δ12) disrupted IFIT2 interaction but retained some HCV RNA binding in cells (though reduced in cell-free assays), suggesting TPR1–2 may facilitate binding indirectly or via cofactors.
• Cofactor Requirement: Purified recombinant IFIT3 failed to bind short m⁶A probes in vitro, whereas lysate-derived IFIT3 did. This suggests IFIT3 requires cellular cofactors or post-translational modifications for high-affinity binding.

C. Antiviral Function and Viral Restriction

• Restriction of Viral Output: Expression of wild-type IFIT3 significantly reduced HCV RNA levels in the supernatant (extracellular) but had no effect on intracellular viral RNA levels.
• Role of the Helical Hairpin: Cells expressing the Δ274–324 mutant (unable to bind RNA) showed no reduction in supernatant viral RNA, indicating that RNA binding is essential for restriction.
• Role of IFIT2 Interaction: Cells expressing the Δ12 mutant (unable to bind IFIT2) showed reduced, but not abolished, antiviral activity, suggesting that while IFIT2 interaction enhances function, the autonomous RNA-binding capability of IFIT3 is the primary driver of restriction.
• m⁶A Landscape: Extracellular HCV RNA showed reduced m⁶A levels and reduced IFIT3 association compared to intracellular RNA, supporting a model where IFIT3 targets m⁶A-marked RNA to prevent its packaging or release.

5. Significance

• New Paradigm for IFIT3: This study redefines IFIT3 from a mere cofactor to an autonomous antiviral effector that directly recognizes viral RNA via a specific chemical modification (m⁶A).
• m⁶A as an Antiviral Signal: While m⁶A on viral RNA is often described as a mechanism for immune evasion (hiding from sensors like RIG-I), this paper reveals a dual role: under interferon stimulation, m⁶A serves as a "flag" for IFIT3-mediated restriction.
• Structural Insight: The identification of the helical hairpin as a dedicated RNA-binding surface provides a new target for understanding IFIT family evolution and potential therapeutic modulation.
• Mechanism of HCV Restriction: The findings suggest IFIT3 restricts HCV at a late stage (packaging/release) by binding m⁶A-modified viral genomes, preventing their efficient export from the cell. This adds a layer of complexity to the host-virus battle over RNA modifications.

In conclusion, the paper establishes that IFIT3 is an m⁶A-dependent RNA-binding protein that utilizes a specific helical hairpin domain to recognize and restrict Hepatitis C Virus, operating independently of its known protein-protein interaction roles.